Opinion: Presidential candidates aren't talking about drug shortages. They should be.

In the conclusion of her recently published book, "Bottle of Lies," Katherine Eban briefly notes that the Food and Drug Administration avoids sanctioning generic manufacturers that sell drugs that are in short supply regardless of how poorly manufactured or counterfeit they are. "Drug shortages had become a game," she writes, "and the FDA was getting played."